Survival and delayed effects of risk-stratified hepatoblastoma patients treated in the JPLT-2 trial.

Eiso Hiyama,Sho Kurihara,Yuka Ueda,Tomoro Hishiki,Kohmei Ida,Ken-ichiro Watanabe,Michihiro Yano,Yukichi Tanaka,Ken Hoshino,Keiko Hiyama

Survival and delayed effects of risk-stratified hepatoblastoma patients treated in the JPLT-2 trial.

2018

Eiso Hiyama
Sho Kurihara
Yuka Ueda
Tomoro Hishiki
Kohmei Ida
Ken-ichiro Watanabe
Michihiro Yano
Yukichi Tanaka
Ken Hoshino
Keiko Hiyama

10524Background: The Japanese Study Group for Pediatric Liver Tumor (JPLT) -2 trial (2000-2012) has been conducting to evaluate the efficacy of the CITA regimen, consisting of cisplatin/pirarubicin...

Keywords:

General surgery
Physical therapy
Hepatoblastoma
Medicine
Regimen
Oncology
Internal medicine
Pirarubicin
Liver tumor
Pathology
Cisplatin

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations